siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo

siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo

Fang Li,1,* ZhiHan Zhu,1,* Man Xue,1,* WanHong He,1 Ting Zhang,1 LingLin Feng,1 ShengXiang Lin2 1NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, and Shanghai Engineer and Technology Research Center of Reproductive Health Drug and...

Full description

Bibliographic Details
Main Authors: Li F, Zhu ZH, Xue M, He WH, Zhang T, Feng LL, Lin SX
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:Drug Design, Development and Therapy
Subjects:
animal model
17β-Hydroxysteroid dehydrogenase type 1
breast cancer
estrogen
siRNA
Online Access:https://www.dovepress.com/sirna-based-breast-cancer-therapy-by-suppressing-17beta-hydroxysteroid-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/sirna-based-breast-cancer-therapy-by-suppressing-17beta-hydroxysteroid-peer-reviewed-article-DDDT

Similar Items